Skip to content

Comment on BioNTech CEO applies Covid-19 vaccine's mRNA tech to multiple sclerosisparent

Comments

Doubtful. Insurances dont run at a loss, every penny that goes into them they take a cut as profits. If the treatment is expensive, great! More demand for their product, and even if their cut is the same, their profit and revenue will be greater.

This doesn't make sense to me. Insurance in a collective risk pooling scheme. How do they take a cut when they are the ones paying out?

There's an 80/20 rule in the ACA [0] where at least 80 percent of the premiums paid must be spent on healthcare costs, otherwise the difference between 80 percent and the actual amount paid must be returned.

Sounds great, until the insurance companies figured out that the best way to make more profit with this profit cap is to pay out more and increase the premiums accordingly. [1] Obviously, the hospitals don't mind that either.

[0] https://www.healthcare.gov/health-care-law-protections/rate-...

[1] https://www.aeaweb.org/research/regulating-health-insurers-a...

So why do they push for generic options instead of the newest and greatest drugs.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.